APAC healthcare markets

• 178Market reports
• 146With size & growth
• 41Markets with active clinical trials
• 12+Key companies named

Health in APAC: WHO figures

APAC: People and health spending

Companies most covered in APAC

All 178 APAC markets

Each market name opens its APAC report. To compare one market across every country, see market statistics.

Digital Health 41 markets

Digital Health markets in APAC

Market	2023	2033 (projected)	CAGR	Active trials
3D Laparoscopy Imaging Systems	$672 Mn	$1.4 Bn	8%	23
3D Printed Implants	$756 Mn	$3 Bn	14.8%	15
3D Printing in Medical Application	$504 Mn	$3.6 Bn	21.6%	35
Artificial Intelligence (AI) in Drugs Discovery	$126 Mn	$1.4 Bn	27.4%	163
Artificial Intelligence (AI) in Healthcare	–	–	–	743
Artificial Intelligence (AI) in Life Sciences	$462 Mn	$5.4 Bn	28%	553
Artificial Intelligence (AI) in Medical Imaging	$189 Mn	$2 Bn	26.5%	233
Artificial Intelligence (AI) in Medicine	$1.7 Bn	$46.2 Bn	38.8%	743
Artificial Intelligence (AI) in Pharma	–	–	–	163
Artificial Intelligence (AI) in Radiology	$126 Mn	$1.7 Bn	29.9%	60
Artificial Intelligence (AI) in Remote Patient Monitoring	$189 Mn	$3 Bn	31.7%	15
Artificial Intelligence (AI) Machine Learning(ML) in Healthcare	$399 Mn	$11 Bn	39.3%	743
Blockchain in Genomics	$468 Mn	$13.1 Bn	39.6%	1
Blockchain-as-a-Service	$441 Mn	$6.3 Bn	30.5%	1
Brain Imaging, Biomarkers and NeuroInformatics	$143 Mn	$255 Mn	6%	982
Brain PET-MRI Systems	$71 Mn	$151 Mn	7.8%	342
Clinical Alarm Management	$365 Mn	$571 Mn	4.6%	25
Clinical Data Management Systems	$525 Mn	$1.8 Bn	13.2%	21
Connected Healthcare Market	$12.3 Bn	$150 Bn	28.4%	98
Decentralized Clinical Trials(DCTs)	$344 Mn	$1.5 Bn	16.1%	763
Dental 3D Printing	$712 Mn	$5.1 Bn	21.8%	8
Dental CAD/CAM	$697 Mn	$2 Bn	11.3%	10
Digital Biomarkers	$924 Mn	$21.2 Bn	36.8%	138
Digital diabetes care	$2.7 Bn	$17.5 Bn	20.6%	124
Digital Pathology Systems	$252 Mn	$1 Bn	15%	305
Digital Therapeutics	$1.4 Bn	$10.7 Bn	22.3%	588
Digital Twin	$357 Mn	$3.5 Bn	25.6%	5
Digital X-ray	$3.7 Bn	$7.2 Bn	7.1%	640
Electronic Health Record	$7.6 Bn	$12.9 Bn	5.5%	224
Healthcare Information System	$60.9 Bn	$329.1 Bn	18.4%	739
Healthcare IT	$101.3 Bn	$364.9 Bn	13.7%	195
Home Healthcare	$76 Bn	$182.8 Bn	9.2%	638
Internet Of Things In Healthcare	$20.9 Bn	$112 Bn	18.3%	5
IoT in Healthcare	$37.9 Bn	$204.8 Bn	18.4%	5
Long-term Care Software	$735 Mn	$2.7 Bn	13.9%	87
Mental Health Apps	$1.2 Bn	$8.6 Bn	22%	52
Pathology Imaging Systems	$340 Mn	$1.2 Bn	13.2%	305
Point of Care Diagnostics	$9.5 Bn	$21.9 Bn	8.7%	1,432
Remote Medication Management	$815 Mn	$4.4 Bn	18.3%	98
Remote Patient Monitoring	$332 Mn	$1.9 Bn	19.1%	128
Werable Healthcare Devices	$6.9 Bn	$46.4 Bn	21.1%	195

Healthcare Services 24 markets

Healthcare Services markets in APAC

Market	2023	2033 (projected)	CAGR	Active trials
Alopecia areata	–	–	–	36
Alzheimers Dignostic	$441 Mn	$967 Mn	8.2%	210
Ambulance Service	$6.6 Bn	$14.7 Bn	8.4%	161
Ambulatory Surgery Center	$8.4 Bn	$17.1 Bn	7.4%	3,332
Antimicrobial Susceptibility Testing	–	–	–	34
Bioinformatics	$2.6 Bn	$11 Bn	15.7%	–
Biomaterial Wound Dressing	$1.7 Bn	$3.7 Bn	8%	35
Blood Gas and Electrolyte Analyzers	$588 Mn	$1.2 Bn	7.7%	158
Bone Cancer Diagnostic	$231 Mn	$531 Mn	8.7%	233
Brain Cancer Diagnostic	$315 Mn	$1.3 Bn	14.9%	373
Breast Cancer Diagnostic	$861 Mn	$2.1 Bn	9.1%	–
Clinical Laboratory Service	–	–	–	–
Dental Care Service	–	–	–	–
Dental Imaging	$714 Mn	$1.7 Bn	9.2%	–
Dermatology Diagnostic	$5.5 Bn	$17.7 Bn	12.5%	1,190
Fertility Service	$4.4 Bn	$9 Bn	7.4%	–
Healthcare Electronic Data Interchange (EDI)	$840 Mn	$2.3 Bn	10.7%	10
Healthcare In Vitro Diagnostic	$17.5 Bn	$28.8 Bn	5.1%	55
Hospitals and Health Systems	$914.8 Bn	$1,777.9 Bn	6.9%	20,278
Medical Billing	$945 Mn	$3.1 Bn	12.7%	19
Medical Tourism	$15.6 Bn	$55.1 Bn	13.5%	3
Nursing Education	$2.2 Bn	$5.3 Bn	9.4%	126
Patient Support Programs (PSP)	$3.6 Bn	$12.7 Bn	17.1%	216
Point Of Care (PoC) Molecular Diagnostic	$3.9 Bn	$10.7 Bn	10.6%	89

Medical Devices 27 markets

Medical Devices markets in APAC

Market	2023	2033 (projected)	CAGR	Active trials
Acute Care Needleless Connectors	$103 Mn	$239 Mn	8.8%	–
Advanced Bipolar Direct Energy Devices	$651 Mn	$1.7 Bn	10%	–
Aesthetic Lasers and Energy Devices	$340 Mn	$1.2 Bn	13.4%	–
Air Ambulance Life Support Solutions	$939 Mn	$2.5 Bn	10.4%	–
Airway Management Devices	$420 Mn	$786 Mn	6.5%	–
Anastomosis Devices	$662 Mn	$1.4 Bn	8.1%	–
Anesthesia & Respiratory Devices	$6 Bn	$16.8 Bn	10.8%	–
Anesthesia Monitoring Devices	$554 Mn	$2 Bn	13.8%	–
Angiography Devices	$2.6 Bn	$5.4 Bn	7.6%	–
Angioplasty Balloons	$853 Mn	$1.4 Bn	5.1%	–
Anti-Snoring Devices	$263 Mn	$685 Mn	10.1%	–
Apheresis Equipments	$533 Mn	$1.1 Bn	7.5%	–
Arrhythmia Monitoring Devices	$1.3 Bn	$2.4 Bn	6.8%	–
Assisted Walking Aids	$483 Mn	$930 Mn	6.8%	–
Audiology Devices	$1.6 Bn	$3.4 Bn	7.7%	–
Defibrillator	$3.7 Bn	$7.4 Bn	7.2%	–
Dental Articulators	$82 Mn	$172 Mn	7.7%	–
Dental Caries Detectors	$78 Mn	$265 Mn	13.1%	–
Dental Diagnostic and Surgical Equipments	$2.5 Bn	$5.6 Bn	8.4%	–
Dental X-Ray Equipments	$368 Mn	$829 Mn	8.5%	–
Diabetes Care Devices	$8.9 Bn	$17.9 Bn	7.2%	–
Digital Diabetes Management	–	–	–	–
Direct Energy Medical Devices	$2.3 Bn	$4.3 Bn	6.3%	–
Disposable Surgical Devices	$1.9 Bn	$4.3 Bn	8.6%	–
Insulin Delivery Devices	$3.3 Bn	$7.1 Bn	7.8%	–
Insulin Patch Pumps	$187 Mn	$650 Mn	13.3%	–
Rehabilitation Equipments	$4.2 Bn	$8.6 Bn	7.4%	–

OTC & Nutraceuticals 48 markets

OTC & Nutraceuticals markets in APAC

Market	2023	2033 (projected)	CAGR	Active trials
Adaptogens	$1.7 Bn	$4.3 Bn	9.8%	–
Amino Acid	–	–	–	–
Anthelmintic Drug	–	–	–	–
Antioxidants	–	–	–	–
Antipyretics OTC	–	–	–	–
BCAA Supplement	$294 Mn	$633 Mn	8%	–
Beauty Supplements	$861 Mn	$2.3 Bn	10.5%	–
Biotin Supplement	$84 Mn	$154 Mn	6.3%	–
Bone & Joint Health Supplements	$2.5 Bn	$5.3 Bn	7.7%	–
Calcium Supplements	$525 Mn	$1.1 Bn	7.3%	–
Cannabidiol (CBD) Supplements	$1.1 Bn	$5.9 Bn	18.1%	–
Cardiovascular Health Supplements	$1.4 Bn	$2.8 Bn	7%	–
Clinical Nutrition	$6 Bn	$13.4 Bn	8.4%	–
Coenzyme Q10	$105 Mn	$279 Mn	10.3%	–
Collagen Supplements	$462 Mn	$941 Mn	7.4%	–
Creatine	$126 Mn	$261 Mn	7.6%	–
Dietary Supplements	$64.7 Bn	$132.9 Bn	7.5%	–
Eye Health Supplements	$651 Mn	$1.3 Bn	7.5%	–
Functional Food	$59.9 Bn	$128.9 Bn	8%	–
Hair Growth Supplements	$378 Mn	$860 Mn	8.6%	–
Herbal Supplements	$17.2 Bn	$40.3 Bn	8.9%	–
Immune Health Supplement	–	–	–	–
Iron Supplement	$420 Mn	$888 Mn	7.8%	–
Men's Health Supplements	$3.8 Bn	$8.3 Bn	8.1%	–
Mood and Stress Supplements	$2.2 Bn	$5.4 Bn	9.4%	–
Nutritional Supplements	$80.9 Bn	$175.7 Bn	8.1%	–
Omega 3 Fatty Acid	$861 Mn	$2 Bn	8.7%	–
Oncology Nutrition	$441 Mn	$1 Bn	8.6%	–
Osteoporosis Supplements	$651 Mn	$1.4 Bn	7.8%	–
Over The Counter (OTC) Analgesics	$4.6 Bn	$7.3 Bn	4.7%	–
Over The Counter (OTC) Antifungal	$525 Mn	$861 Mn	5.1%	–
Over The Counter (OTC) Consumer	$31.7 Bn	$59.4 Bn	6.5%	–
Over The Counter (OTC) Drugs	$37.4 Bn	$66.8 Bn	6%	–
Over The Counter (OTC) Gastrointestinal Drugs	$1.2 Bn	$1.9 Bn	5.2%	–
Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs	$3 Bn	$5.1 Bn	5.4%	–
Over The Counter (OTC) Ophthalmic Drugs	$756 Mn	$1.3 Bn	5.8%	–
Over The Counter (OTC) Pharmaceuticals	$37.4 Bn	$66.8 Bn	6%	–
Over The Counter (OTC) Sleep Aid Products	$1.1 Bn	$1.9 Bn	5.3%	–
Over The Counter (OTC) Vitamins and Minerals	$6.7 Bn	$12.9 Bn	6.8%	–
Plant-Based Supplements	$2.6 Bn	$6.3 Bn	9.3%	–
Prebiotics	$1.7 Bn	$5.8 Bn	13.1%	–
Probiotic Supplements for Gut Health	$1.3 Bn	$2.9 Bn	8.5%	–
Protein Supplement	$4.2 Bn	$9.6 Bn	8.7%	–
Sports Nutrition	$10.9 Bn	$26.3 Bn	9.2%	–
Vitamin B12(Cobalamin)	$63 Mn	$121 Mn	6.8%	–
Vitamin D Supplements	–	–	–	–
Weight Management Supplement	–	–	–	–
Women's Health Supplements	$4.2 Bn	$9.1 Bn	8.1%	–

Pharmaceuticals 38 markets

Pharmaceuticals markets in APAC

Market	2023	2033 (projected)	CAGR	Active trials
Abuse Deterrent Opioids	–	–	–	–
Alexipharmic Drugs	–	–	–	–
Alopecia Drugs (Hair Loss)	–	–	–	–
Alzheimer Drugs	$441 Mn	$967 Mn	8.2%	–
Aminoglycosides	–	–	–	–
Anemia Drugs	–	–	–	–
Anti-Aging	$18.5 Bn	$45.4 Bn	9.4%	–
Anti-Depressants Drugs	$3.8 Bn	$5.6 Bn	4%	–
Anti-Nerve Growth Factor	–	–	–	–
Anti-Venom	–	–	–	–
Anticoagulants	–	–	–	–
Antithrombotic Drugs	–	–	–	–
Artificial Skin	$525 Mn	$1 Bn	7.1%	–
Asthma & COPD Drugs	$10.4 Bn	$17.4 Bn	5.3%	–
Atherosclerosis Drugs	–	–	–	–
Atopic Dermatitis Drugs	$2.4 Bn	$8.3 Bn	13.5%	–
Autologous Matrix-induced Chondrogenesis	–	–	–	–
Axial Spondyloarthritis (axSpA)	–	–	–	–
Biological Safety Testing	–	–	–	–
Biosimilar Monoclonal Antibodies	–	–	–	–
Biosimilars	$7.7 Bn	$79.2 Bn	26.2%	–
Blood Plasma	–	–	–	–
Bone Marrow Aspirate Concentrates	–	–	–	–
Burn Care	–	–	–	–
Burn Ointment	–	–	–	–
Cancer Supportive Care Drugs	$5.2 Bn	$9.3 Bn	6%	–
Cannabidiol (CBD)	$4.6 Bn	$24.4 Bn	18.1%	–
Cannabis	$7.1 Bn	$28.2 Bn	14.8%	–
Cell Based Immunotherapy	$3.5 Bn	$30.6 Bn	24.3%	–
Contraceptives Drugs	$5.3 Bn	$11.5 Bn	8.1%	–
Cord Blood Banking Service	$399 Mn	$843 Mn	7.8%	–
Diabetes Management	$16.4 Bn	$36.6 Bn	8.4%	–
Diabetic Retinopathy Drugs	$2.3 Bn	$4.6 Bn	7.3%	–
Epilepsy Drugs	$2 Bn	$3.2 Bn	4.8%	–
Gastroesophageal Reflux Disease (GERD) Drugs	$1.1 Bn	$1.5 Bn	3.4%	–
Gastrointestinal Drugs	$11.3 Bn	$20.1 Bn	5.9%	–
HIV Drugs	$6.3 Bn	$12.5 Bn	7.1%	–
Oncology/Cancer Drugs	$37.2 Bn	$93.6 Bn	9.7%	–

"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.

Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.

All 178 APAC reports Other countries